Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results

Rhea-AI Summary

• English
• French
• German
• Italian
• Korean
• Spanish

Artivion, Inc. (NYSE: AORT) will release its first quarter 2024 financial results on May 6, 2024, followed by a teleconference call and webcast hosted by Pat Mackin, the Chairman, President, and CEO. Investors can access the live event by dialing 201-689-8261 or visiting the company's website. The earnings press release with financial and statistical information will be available on the Artivion website for further details.

ATLANTA, April 22, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2024 financial results will be released on Monday, May 6, 2024 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13744600. 

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:

Artivion Lance A. Berry Executive Vice President & Chief Financial Officer Phone: 770-419-3355

Gilmartin Group LLC Brian Johnston / Laine Morgan Phone: 332-895-3222 investors@artivion.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-first-quarter-2024-financial-results-302123717.html

SOURCE Artivion

FAQ

When will Artivion release its first quarter 2024 financial results?

Artivion will release its first quarter 2024 financial results on May 6, 2024.

Who will host the teleconference call and webcast for Artivion's first quarter 2024 financial results?

Pat Mackin, the Chairman, President, and CEO of Artivion, will host the teleconference call and webcast.

How can investors access the live teleconference for Artivion's financial results?

Investors can access the live teleconference by dialing 201-689-8261 a few minutes prior to 4:30 p.m. ET on May 6, 2024.

Where can investors find the earnings press release with financial and statistical information for Artivion's first quarter 2024 results?

Investors can find the earnings press release on the Investors section of the Artivion website.

What is the conference number for the teleconference replay of Artivion's first quarter 2024 financial results?

The conference number for the replay is 13744600.